Anteilseigner
Richard E. Uihlein (16,65 %) 10X Capital Management LLC (9,62 %) The Vanguard Group, Inc. (3,11 %) Osaic Wealth, Inc. (Investment Management) (2,02 %) Kevin D. Freeman (1,19 %) BlackRock Fund Advisors (1,15 %) Kary Noel Eldred (1,07 %) Geode Capital Management LLC (0,83 %) Geneos Wealth Management, Inc. (0,67 %) Western International Securities, Inc. (0,40 %) Wealthspire Advisors LLC (0,30 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,29 %) SSgA Funds Management, Inc. (0,26 %) Cambridge Investment Research Advisors, Inc. (0,20 %) Cutter & Co. Brokerage, Inc. (Investment Management) (0,19 %) 683 Capital Management LLC (0,18 %) Commonwealth Equity Services LLC (0,17 %) Northern Trust Investments, Inc.(Investment Management) (0,16 %)
Kontakt
Galectin Therapeutics Inc.
Suite 34, Wells Avenue 7
02459 Newton